Global Halobetasol Market 2023-2030

    In Stock

    Coming Soon.




    When certain skin disorders are present, halobetasol topical is used to reduce any redness, itching, swelling, or other pain. Plaque psoriasis can also be treated with it. The drug in question is a corticosteroid (cortisone-like medicine or steroid).


    Only a doctor’s prescription is required to purchase this medication. An extremely potent steroid drug called halobetasol (Ultravate) is applied to the skin to reduce swelling and irritation brought on by specific skin diseases. Adults and children who are at least 12 years old— Apply to the skin’s afflicted region twice daily for up to two weeks. Children under the age of 12 should not use this.


    Halobetasol is a member of the corticosteroid family. Prostaglandins are chemical messengers that cause the affected area to become red, bloated, and itching. It prevents their formation.




    Infographic: Halobetasol Market, Halobetasol Market Size, Halobetasol Market Trends, Halobetasol Market Forecast, Halobetasol Market Risks, Halobetasol Market Report, Halobetasol Market Share


    The Global HALOBETASOL market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    In the US, Mayne Pharma introduces Lexette (TM) (halobetasol propionate) foam 0.05%. A new formulation of halobetasol, a strong topical corticosteroid intended for the treatment of plaque psoriasis in adult patients, is known as LEXETTE. It is a conditionally permitted trade name for halobetasol foam.


    THE US FOOD AND DRUG ADMINISTRATION APPROVED LEXETTE (FDA) Psoriasis patients will have new treatment options thanks to the sophisticated foam composition LEXETTE. Dermatologists value the foam delivery platform’s reputation for ease of use, lack of greasiness, and stickiness, especially in hair-bearing areas and under garments.


    The psoriasis-focused sales staff that now supports LEXETTE will now be able to offer a strong steroid coupled with steroid-free SORILUX® Foam, both of which are frequently used in Protocols for treating psoriasis. 


    Among the more than 60 products that Mayne Pharma sells directly in the US are four branded dermatology products: FABIOR® (tazarotene) Foam, SORILUX (calcipotriene) Foam, DORYX® MPC (doxycycline hyclate) delayed-release tablets, and LEXETTE (halobetasol propionate) Foam.


    TolsuraTM (SUBA®-itraconazole) pills, which the company just launched and for which it recently acquired approval, are used to treat specific fungal infections.A specialist pharmaceutical firm with an ASX listing, Mayne Pharma is committed to using its knowledge of drug delivery to market both branded and generic medications.


    More than 100 companies worldwide get contract manufacturing and development services from Mayne Pharma.





    1. How many HALOBETASOL are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global  HALOBETASOL and key vendor selection criteria
    3. Where is the HALOBETASOL manufactured? What is the average margin per unit?
    4. Market share of Global  HALOBETASOL market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global HALOBETASOL in-house
    6. key predictions for next 5 years in Global HALOBETASOL market
    7. Average B-2-B HALOBETASOL market price in all segments
    8. Latest trends in HALOBETASOL market, by every market segment
    9. The market size (both volume and value) of the HALOBETASOL market in 2023-2030 and every year in between?
    10. Production breakup of HALOBETASOL market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop